The cause of uraemic pruritus is unknown. In some cases it may be due to secondary hyperparathyroidism. Only in these patients is parathyroidectomy indicated.2 The mechanisms of other treatments such as ultraviolet light3 or cholestyramine4 are unknown and are effective in only some cases. In our patient the rapid and complete disappearance of pruritus after lowering the dialysate magnesium concentration suggests a causative relation between itching and serum magnesium concentration. Lowering the dialysate magnesium concentration is known to restore nerve conduction velocity towards normal in patients receiving CHD,5 and this could be the reason for the complete disappearance of the pruritus in our patient.
A tube spacer to improve inhalation of drugs from pressurised aerosols Inhalation from pressurised aerosols provides an effective means of drug administration with a low incidence of side effects, but many patients cannot co-ordinate inhalation with aerosol actuation.' Another potential disadvantage of pressurised aerosols is the deposition of drug on to the mucosa of the mouth and oropharynx caused by the high velocity of the flow of drug particles produced by aerosol actuation directly into the mouth. It has been shown,2 however, that the interposition of a tube spacer between the aerosol and the mouth reduces deposition of drug and also that the drug remains suspended in the system for several seconds, thus enabling inhalation to be delayed after aerosol actuation. This study was designed to test the hypothesis that a tube spacer could improve drug inhalation in patients unable to use aerosols efficiently.
Patients, methods, and results
Sixteen patients with chronic asthma (age range 62-77 years, 10 men) were studied. All had a forced expiratory volume in one second (FEV1) less than 70 % of predicted normal, and the pretreatment FEV1 did not vary by more than 12 5 % between study days. Each patient received four separate treatments on different days. All bronchodilator treatment was withheld for 12 hours before each test. The order of treatment was randomised. The four treatments were: (a) 500 ug terbutaline from the conventional aerosol with actuation of aerosol at the beginning of inspiration; (b) 500 tLg terbutaline from a conventional aerosol with a spacer 10 cm long and 3-2 cm in diameter attached-inhalation and actuation were coordinated; (c) 500 tLg terbutaline from a conventional aerosol with a spacer 10 cm long and 3-2 cm in diameter attached-inhalation was delayed two seconds after actuation of aerosol; (d) 500 ,tg terbutaline from a conventional aerosol-inhalation was delayed two seconds after actuation of aerosol.
FEV1, forced vital capacity (FVC), peak expiratory flow rate (PEFR), and pulse rate were measured before and 5, 10, 20, 30, 60, 120, 180, Clostridium difficile-associated colitis after neomycin treated with metronidazole Clostridium difficile-associated colitis is being increasingly recognised after antibiotic treatment. The following case is the first to be documented after oral neomycin and was successfully treated with oral metronidazole.
Case report
A 65-year-old man with longstanding alcoholic cirrhosis was admitted with hepatic decompensation causing ascites and encephalopathy. Protein and salt restriction, oral lactulose, spironolactone, and neomycin (1 g four times daily) produced good improvement and he was discharged. Eight days after stopping neomycin he developed abdominal pain and bloody diarrhoea 8-10 times daily. This failed to settle over the next seven days, and on readmission he was dehydrated, febrile, and jaundiced but had no encephalopathy. Sigmoidoscopy showed grossly active colitis with ulceration, pus, and bleeding to the limit of examination, but there was no pseudomembrane. A stool sample was cultured in Reinforced Clostridial Medium with 0-2% paracresoll and grew Cl difficile as identified morphologically and biochemic- Exertional hypotension is often seen in patients with various cardiac disorders' including severe coronary artery stenosis,2 and in normal subjects during maximal exhaustive exercise. We describe a patient with mild ischaemic heart disease who developed syncopal episodes after running and a definite fall in blood pressure accompanying bradycardia after exercise.
A 48-year-old trained soldier was admitted on 7 May 1979 because of syncopal episodes after running. In the seven years before admission he had had several episodes of syncope while he was standing still after running 1-2 km, especially on cold mornings; he did not suffer syncopal attacks when he jogged instead of suddenly stopping running. Two figure, a) . The fall of blood pressure after exercise disappeared by giving pindolol, 20 mg orally ( figure, b) .
His response to Valsalva manoeuvre, cold pressor test, and mental arithmetic test was normal. Plasma norepinephrine, epinephrine, and dopamine concentrations were, respectively, 260 ng/l, 25 ng/l, and 115 ng/l in a supine position and 706 ng/l, 98 ng/l, and 278 ng/l in an upright position for 10 minutes. Blood gas, plasma lactate, and plasma pyruvate values before and after exercise were normal.
Comment
Thomson and Kelemen3 stated that a fall in systolic pressure during exercise is a sign that the left ventricular blood supply is severely compromised. Levites et a12 found hypotension during exercise testing in 2-7% of the patients they tested, but the extent and distribution of coronary lesions were no different from those of patients with a normal blood pressure response to exercise. In their patients hypotension occurred during exercise but not after it. In our patient the extent of coronary artery narrowing was not significant and seemed unlikely to have caused the syncope and fall in blood pressure after exercise. His normal response to the Valsalva manoeuvre indicated an intact baroreceptor reflex arch. Another possible explanation of the syncope is a vasodepressor syncope associated with exercise. A betablocker prevented the fall in blood pressure and bradycardia in this patient, which suggested that the syncope may have been caused by a ,-receptor-mediated neurogenic or metabolic mechanism induced by exercise.
